What is SCIENTIFIC INDUSTRIES INC's earnings per share (EPS)?

SCIENTIFIC INDUSTRIES INC (SCND) reported diluted earnings per share of -$0.11 for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SCIENTIFIC INDUSTRIES INC (SCND) Financials

SCND

Trailing 12 months to June 30, 2026

Revenue $5.7M YoY not available

Net Income -$741K YoY not available

EPS (Diluted) -$0.06 +89.7% YoY

Free Cash Flow -$6.9M -52.7% YoY

Market Cap $8.2M as of Oct 9, 2026

Price / Sales 1.4x on $5.7M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.0x on $8.1M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SCND SEC filings page.

SCIENTIFIC INDUSTRIES INC (SCND) reported $5.7M in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SCND FY2025 2026-10-04

The business remains structurally loss-making: shrinking revenue and gross margin have overwhelmed lower overhead, while cash consumption worsened.

Gross margin fell from 45.9% in FY2023 to 25.8% in FY2025 even as SG&A and R&D were reduced, so cost reductions did not offset weaker gross-profit generation. The sharpest earnings-quality split is in FY2025: net loss narrowed to $1.2M, but operating cash flow reached -$8.1M, with financing and investing inflows doing the offsetting work rather than operations.

FY2025 debt-to-equity was 0.2x and current ratio was 7.7x, indicating reported obligations are modest relative to equity and current assets. Yet its liquidity measure equaled 9.8 months of latest annual reported operating outflow while operating cash flow was -$8.1M, making the financing structure more conservative than the operating performance.

R&D was $2.5M against revenue of $5.1M in FY2025, showing a development-heavy cost structure even after that spending declined. Free cash flow was -$8.2M versus operating cash flow of -$8.1M, so capital spending was not the main drain; most of the shortfall arose before investing.

Financial Health Signals

Financial health score not available

SCIENTIFIC INDUSTRIES INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-2.19

SCIENTIFIC INDUSTRIES INC scores -2.19, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($8.2M) relative to total liabilities ($1.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

SCIENTIFIC INDUSTRIES INC passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

SCIENTIFIC INDUSTRIES INC reported a net loss of $1.2M while operations used $8.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.5M

YoY+36.0%

QoQ+19.8%

SCIENTIFIC INDUSTRIES INC generated $1.5M in revenue in Q2 2026. This represents an increase of 36.0% from the same quarter a year earlier. Against the prior quarter it is up 19.8%.

EBITDA

-$1.2M

YoY+26.6%

QoQ+24.2%

SCIENTIFIC INDUSTRIES INC's EBITDA was -$1.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.6% from the same quarter a year earlier. Against the prior quarter it is up 24.2%.

Net Income

-$1.2M

YoY+19.0%

QoQ+22.4%

SCIENTIFIC INDUSTRIES INC reported -$1.2M in net income in Q2 2026. This represents an increase of 19.0% from the same quarter a year earlier. Against the prior quarter it is up 22.4%.

EPS (Diluted)

-$0.10

YoY+23.1%

QoQ+23.1%

SCIENTIFIC INDUSTRIES INC earned -$0.10 per diluted share (EPS) in Q2 2026. This represents an increase of 23.1% from the same quarter a year earlier. Against the prior quarter it is up 23.1%.

Cash & Balance Sheet

Free Cash Flow

-$912K

YoY+46.0%

QoQ+8.7%

SCIENTIFIC INDUSTRIES INC recorded an outflow of $912K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 46.0% from the same quarter a year earlier. Against the prior quarter it is up 8.7%.

Cash & Debt

$617K

YoY-30.8%

QoQ-22.7%

5Y CAGR-42.3%

10Y CAGR-6.8%

SCIENTIFIC INDUSTRIES INC held $617K in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

12M

YoY+3.2%

QoQ0.0%

5Y CAGR+13.1%

10Y CAGR+23.1%

SCIENTIFIC INDUSTRIES INC had 12M shares outstanding in Q2 2026. This represents an increase of 3.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

42.4%

YoY+7.5pp

QoQ+4.1pp

SCIENTIFIC INDUSTRIES INC's gross margin was 42.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 7.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Operating Margin

-86.6%

SCIENTIFIC INDUSTRIES INC's operating margin was -86.6% in Q2 2026, reflecting core business profitability. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

-83.9%

SCIENTIFIC INDUSTRIES INC's net profit margin was -83.9% in Q2 2026, showing the share of revenue converted to profit. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

-15.3%

YoY+4.0pp

QoQ+2.2pp

SCIENTIFIC INDUSTRIES INC's ROE was -15.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Capital Allocation

R&D Spending

$695K

YoY+2.6%

QoQ-1.3%

SCIENTIFIC INDUSTRIES INC invested $695K in research and development in Q2 2026. This represents an increase of 2.6% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.

Capital Expenditures

$8K

YoY+20.3%

QoQ+33.9%

5Y CAGR-11.2%

10Y CAGR-15.9%

SCIENTIFIC INDUSTRIES INC invested $8K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 20.3% from the same quarter a year earlier. Against the prior quarter it is up 33.9%.

Share Buybacks

Not reported for Q2 2026.

SCND Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCND quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$5.7M	$5.1M+5.4%	$4.8M-56.8%	$11.1M-2.5%	$11.4M+16.6%	$9.8M+25.6%	$7.8M-23.7%	$10.2M+20.3%	$8.5M+4.1%	$8.1M-15.1%	$9.6M+22.3%	$7.8M+15.5%	$6.8M-4.8%	$7.1M+15.0%	$6.2M+5.7%	$5.9M
Cost of Revenue	$4.1M	$3.8M+34.4%	$2.8M-53.6%	$6.0M+6.1%	$5.7M+18.0%	$4.8M+24.8%	$3.8M-34.0%	$5.8M+10.9%	$5.3M-0.2%	$5.3M-7.2%	$5.7M+20.2%	$4.7M+13.1%	$4.2M+0.1%	$4.2M+8.6%	$3.8M+11.1%	$3.5M
Gross Profit	$1.7M	$1.3M-35.1%	$2.0M-60.7%	$5.1M-11.1%	$5.7M+15.3%	$5.0M+26.4%	$3.9M-9.8%	$4.4M+35.6%	$3.2M+11.9%	$2.9M-26.5%	$3.9M+25.5%	$3.1M+19.4%	$2.6M-11.6%	$3.0M+25.5%	$2.4M-2.1%	$2.4M
R&D Expenses	$2.6M	$2.5M-14.2%	$2.9M-18.7%	$3.6M+24.1%	$2.9M+76.9%	$1.6M+42.5%	$1.1M+114.8%	$531K+1.8%	$521K+19.1%	$438K+25.4%	$349K-11.0%	$392K-8.1%	$427K-5.3%	$451K+19.8%	$376K+15.9%	$324K
SG&A Expenses	$2.8M	$3.3M-20.6%	$4.1M-24.0%	$5.4M-6.9%	$5.8M+44.4%	$4.0M+77.0%	$2.3M+18.2%	$1.9M+10.0%	$1.7M+5.0%	$1.7M-1.8%	$1.7M-0.3%	$1.7M+12.4%	$1.5M+18.4%	$1.3M+3.8%	$1.2M+4.7%	$1.2M
Operating Income	-$6.9M	-$7.9M+4.0%	-$8.2M+11.3%	-$9.3M+19.8%	-$11.5M-145.2%	-$4.7M-609.7%	-$664K-185.5%	$776K+14210.9%	-$6K+96.6%	-$160K-165.5%	$245K+1558.3%	-$17K+85.8%	-$119K-123.4%	$507K+1282.6%	$37K-86.4%	$271K
EBITDA	N/A	-$7.3M+2.5%	-$7.5M+12.2%	-$8.5M+21.6%	-$10.9M-143.6%	-$4.5M-786.8%	-$503K-148.6%	$1.0M+244.9%	$300K+53.2%	$196K-71.0%	$674K+61.2%	$418K+190.1%	$144K-79.0%	$686K+208.3%	$223K-51.5%	$459K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2K-11.8%	$2K-41.4%	$3K-91.4%	$34K+707.1%	$4K+35.5%	$3K-35.4%	$5K+4.3%	$5K	N/A
Income Tax	N/A	$5K	$0	$0-100.0%	$2.4M+307.8%	-$1.2M-164.0%	-$437K-450.4%	$125K-23.0%	$162K+318.2%	-$74K-239.2%	$53K+433.1%	-$16K+49.5%	-$32K-125.5%	$124K+3061.9%	-$4K-105.3%	$80K
Net Income	-$741K	-$1.2M+81.1%	-$6.4M+29.1%	-$9.1M+33.5%	-$13.7M-272.2%	-$3.7M-422.2%	-$703K-208.9%	$646K+502.2%	-$161K-121.1%	-$73K-143.8%	$166K+1803.4%	$9K+111.6%	-$75K-119.0%	$396K+499.7%	$66K-71.0%	$228K
EPS (Basic)	N/A	N/A	N/A	-$1.27+38.3%	-$2.06-106.0%	-$1.00-117.4%	-$0.46-207.0%	$0.43+490.9%	-$0.11-120.0%	-$0.05-145.5%	$0.11+1000.0%	$0.01+120.0%	-$0.05-116.7%	$0.30+500.0%	$0.05-73.7%	$0.19
EPS (Diluted)	-$0.06	-$0.11+82.0%	-$0.61+52.0%	-$1.27	N/A	-$1.00	-$0.46	$0.43+490.9%	-$0.11-120.0%	-$0.05-145.5%	$0.11	$0.01	-$0.05-116.7%	$0.30+500.0%	$0.05-73.7%	$0.19
Diluted Shares (Avg)	N/A	11M+8.0%	11M+3.5%	10M+52.8%	7M+108.1%	3M	2M	2M+1.2%	1M+0.2%	1M+0.1%	1M	1M	1M+3.2%	1M+3.8%	1M+6.6%	1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.5M+36.0%	$1.2M+30.2%	$1.6M	$1.4M+5.2%	$1.1M-59.2%	$942K-62.1%	N/A	$1.3M-48.4%
Cost of Revenue	$848K+20.4%	$757K+26.6%	$1.7M	$765K+16.9%	$704K-48.0%	$598K-58.5%	N/A	$655K-53.4%
Gross Profit	$623K+65.3%	$470K+36.5%	-$57K	$639K-6.1%	$377K-70.9%	$344K-66.9%	N/A	$680K-42.4%
R&D Expenses	$695K+2.6%	$704K+7.9%	$537K	$621K-3.5%	$677K+1.7%	$652K-8.3%	N/A	$644K-28.1%
SG&A Expenses	$554K-25.6%	$747K-27.4%	$692K	$804K+2.9%	$745K-29.9%	$1.0M-32.4%	N/A	$781K-12.9%
Operating Income	-$1.3M+30.0%	-$1.7M+20.2%	-$2.5M	-$1.5M+2.8%	-$1.8M-36.2%	-$2.1M0.0%	N/A	-$1.6M+29.6%
EBITDA	-$1.2M+26.6%	-$1.6M+16.1%	-$2.3M	-$1.4M-0.5%	-$1.7M-45.2%	-$1.9M-1.1%	N/A	-$1.4M+32.4%
Income Tax	$0	$0	N/A	N/A	$0	$0	N/A	$0
Net Income	-$1.2M+19.0%	-$1.6M+10.6%	-$1.9M	$4.0M+438.5%	-$1.5M-18.7%	-$1.8M+13.3%	N/A	-$1.2M+46.4%
EPS (Basic)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.11+64.5%
EPS (Diluted)	-$0.10+23.1%	-$0.13+18.8%	-$0.17+5.6%	$0.34+409.1%	-$0.13-8.3%	-$0.16-180.0%	-$0.18+37.9%	-$0.11
Diluted Shares (Avg)	12M+5.1%	12M+13.6%	N/A	12M+11.5%	11M+8.0%	11M+0.6%	N/A	11M

Not reported in any period shown, so not listed: Interest Expense.

SCND Balance Sheet

SCND quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$12.6M+9.1%	$11.6M-30.9%	$16.7M-20.4%	$21.0M-27.6%	$29.0M+96.0%	$14.8M+78.8%	$8.3M+13.0%	$7.3M+7.3%	$6.8M-9.6%	$7.5M+5.7%	$7.1M+0.4%	$7.1M+15.6%	$6.2M+6.6%	$5.8M+15.1%	$5.0M
Current Assets	$10.4M+25.4%	$8.3M-32.8%	$12.3M-24.1%	$16.3M-11.7%	$18.4M+44.7%	$12.7M+93.2%	$6.6M+22.2%	$5.4M+18.7%	$4.5M-15.4%	$5.4M+18.2%	$4.5M+8.6%	$4.2M-7.1%	$4.5M+13.6%	$4.0M-4.2%	$4.1M
Cash & Equivalents	$955K+62.4%	$588K-26.2%	$796K-73.2%	$3.0M-69.3%	$9.7M+28.0%	$7.6M+371.7%	$1.6M+52.2%	$1.1M+2.7%	$1.0M-17.7%	$1.2M+158.3%	$482K-2.4%	$494K-46.8%	$927K+20.5%	$769K-15.3%	$908K
Short-Term Investments	$5.7M	$0	$0-100.0%	$6.4M+70.7%	$3.7M+1028.6%	$332K+0.3%	$331K+5.1%	$315K+6.5%	$296K+1.9%	$290K+2.9%	$282K-32.2%	$415K-54.3%	$908K+26.5%	$718K+3.6%	$693K
Inventory	$1.7M-15.1%	$2.1M-57.8%	$4.9M+4.0%	$4.7M+57.7%	$3.0M+17.2%	$2.5M-2.0%	$2.6M+14.3%	$2.3M+15.6%	$2.0M-18.7%	$2.4M+9.0%	$2.2M-4.1%	$2.3M+35.4%	$1.7M+5.7%	$1.6M-1.6%	$1.6M
Accounts Receivable	$866K+48.8%	$582K-49.7%	$1.2M-22.9%	$1.5M+16.0%	$1.3M+21.7%	$1.1M-46.1%	$2.0M+14.6%	$1.7M+46.1%	$1.2M-4.3%	$1.2M+13.9%	$1.1M+42.9%	$757K-7.3%	$816K+30.9%	$624K+0.6%	$620K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$115K0.0%	$115K0.0%	$115K0.0%	$115K-97.4%	$4.4M+1608.3%	$257K-63.5%	$705K0.0%	$705K0.0%	$705K0.0%	$705K0.0%	$705K0.0%	$705K+19.6%	$590K0.0%	$590K+31.7%	$448K
Total Liabilities	$1.9M-20.3%	$2.4M-14.2%	$2.8M-18.0%	$3.5M+24.7%	$2.8M-9.6%	$3.1M+58.9%	$1.9M+19.2%	$1.6M+62.4%	$1000K-38.2%	$1.6M+16.3%	$1.4M-2.9%	$1.4M+89.5%	$756K+2.3%	$739K+79.2%	$412K
Current Liabilities	$1.3M-22.8%	$1.7M-4.9%	$1.8M-17.6%	$2.2M-2.5%	$2.3M+4.5%	$2.2M+38.0%	$1.6M+24.5%	$1.3M+56.7%	$813K-39.1%	$1.3M+18.1%	$1.1M+8.5%	$1.0M+53.7%	$678K+24.2%	$546K+32.3%	$412K
Non-Current Liabilities	$595K-14.3%	$694K-31.1%	$1.0M-18.7%	$1.2M+150.5%	$495K-44.3%	$888K+153.7%	$350K0.0%	$350K+87.1%	$187K-33.7%	$282K+8.5%	$260K-33.4%	$391K+399.4%	$78K-59.5%	$193K	$0
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$0	N/A	$0-100.0%	$6K-53.6%	$13K	$0	$0-100.0%	$27K-74.6%	$105K	$0
Total Equity	$10.7M+16.9%	$9.1M-34.3%	$13.9M-20.8%	$17.5M-33.1%	$26.2M+123.7%	$11.7M+84.9%	$6.3M+11.2%	$5.7M-2.2%	$5.8M-1.8%	$5.9M+3.2%	$5.8M+1.3%	$5.7M+5.2%	$5.4M+7.2%	$5.0M+9.4%	$4.6M
Retained Earnings	-$35.2M-3.6%	-$33.9M-23.5%	-$27.5M-91.9%	-$14.3M-2099.2%	-$651K-121.5%	$3.0M-18.9%	$3.7M+18.9%	$3.1M-4.9%	$3.3M-3.4%	$3.4M+5.1%	$3.2M+0.3%	$3.2M-5.3%	$3.4M+11.6%	$3.1M+0.2%	$3.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$10.1M-1.2%	$11.1M+5.0%	$12.6M+9.1%	$14.6M+9.4%	$10.2M-28.4%	$10.6M-32.0%	$11.6M-30.9%	$13.3M+2.0%
Current Assets	$8.1M+12.7%	$9.0M+21.6%	$10.4M+25.4%	$11.9M+23.2%	$7.2M-30.6%	$7.4M-35.2%	$8.3M-32.8%	$9.7M+12.6%
Cash & Equivalents	$617K-30.8%	$798K+69.7%	$955K+62.4%	$1.2M+106.3%	$891K+59.0%	$470K+33.7%	$588K-26.2%	$564K+9.3%
Short-Term Investments	$3.9M	$0	$5.7M	$0	$0	$0	$0	$0
Inventory	$1.9M-55.8%	$1.6M-64.0%	$1.7M-15.1%	$2.0M-62.0%	$4.4M-18.6%	$4.4M-10.6%	$2.1M-57.8%	$5.4M+2.0%
Accounts Receivable	$517K-46.5%	$535K-55.7%	$866K+48.8%	$678K-50.1%	$966K-20.5%	$1.2M+5.4%	$582K-49.7%	$1.4M+5.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%
Total Liabilities	$2.0M-8.9%	$2.0M-29.1%	$1.9M-20.3%	$2.1M-11.7%	$2.2M-14.0%	$2.8M-4.3%	$2.4M-14.2%	$2.4M-25.2%
Current Liabilities	$1.6M-5.5%	$1.4M-32.2%	$1.3M-22.8%	$1.6M-3.5%	$1.7M-4.4%	$2.1M+4.0%	$1.7M-4.9%	$1.6M-26.2%
Non-Current Liabilities	$430K-19.5%	$543K-18.9%	$595K-14.3%	$542K-28.8%	$535K-34.7%	$669K-23.7%	$694K-31.1%	$762K-22.9%
Total Equity	$8.1M+1.9%	$9.1M+17.3%	$10.7M+16.9%	$12.5M+14.0%	$7.9M-32.2%	$7.8M-38.4%	$9.1M-34.3%	$10.9M+10.7%
Retained Earnings	-$38.0M-2.0%	-$36.7M-2.9%	-$35.2M-3.6%	-$33.2M-3.9%	-$37.2M-20.8%	-$35.7M-20.9%	-$33.9M-23.5%	-$32.0M-26.7%

Not reported in any period shown, so not listed: Long-Term Debt.

SCND Cash Flow Statement

SCND quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$6.8M	-$8.1M-121.2%	-$3.7M+40.2%	-$6.2M-18.6%	-$5.2M-45.0%	-$3.6M-2029.7%	-$168K-114.5%	$1.2M+351.3%	$257K+457.3%	$46K-94.8%	$880K+497.3%	$147K+321.1%	$35K-93.8%	$564K+70.1%	$332K-49.1%	$653K
Depreciation & Amortization	N/A	$610K-18.7%	$751K-0.4%	$754K+9.6%	$688K+173.6%	$252K+56.3%	$161K-37.5%	$257K-15.7%	$305K-14.3%	$356K-17.0%	$429K-1.4%	$435K+65.4%	$263K+47.0%	$179K-3.8%	$186K-1.3%	$188K
Stock-Based Compensation	N/A	$521K-55.3%	$1.2M-48.0%	$2.2M-4.7%	$2.4M+11.5%	$2.1M+3103.6%	$66K+40.6%	$47K+56.0%	$30K+1263.6%	$2K-81.4%	$12K+8.3%	$11K-31.9%	$16K+88.2%	$9K+21.4%	$7K-67.1%	$21K
Capital Expenditures	$45K	$63K-36.1%	$99K-24.9%	$132K-82.6%	$758K+281.3%	$199K+290.4%	$51K-72.9%	$188K+205.9%	$61K+261.2%	$17K-81.5%	$92K+36.7%	$67K+34.9%	$50K+33.1%	$38K-50.2%	$75K+18.4%	$64K
Free Cash Flow	-$6.9M	-$8.2M-117.1%	-$3.8M+39.8%	-$6.3M-5.7%	-$5.9M-57.4%	-$3.8M-1625.5%	-$219K-122.5%	$972K+397.0%	$196K+571.8%	$29K-96.3%	$788K+884.3%	$80K+637.6%	-$15K-102.8%	$527K+105.4%	$257K-56.4%	$589K
Investing Cash Flow	$4.0M	$3.8M+33.7%	$2.9M+489.9%	-$735K+80.4%	-$3.7M+65.6%	-$10.9M-12841.7%	-$84K+61.5%	-$218K-174.7%	-$80K-93.4%	-$41K-121.1%	$194K+177.5%	-$251K+3.2%	-$259K-2.1%	-$254K+27.6%	-$350K-29.9%	-$270K
Financing Cash Flow	$500K	$2.0M+202.3%	$646K-88.8%	$5.8M+149.3%	$2.3M-86.1%	$16.6M+167.2%	$6.2M+1685.2%	-$392K-162.2%	-$149K+33.6%	-$225K+27.9%	-$312K-440.4%	$92K+143.7%	-$210K-37.3%	-$153K-27.3%	-$120K-11.4%	-$108K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$45K	N/A	N/A	N/A	N/A	$60K-44.5%	$108K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$904K+46.3%	-$994K+34.7%	-$3.8M-848.0%	-$1.2M+32.2%	-$1.7M-93.0%	-$1.5M+2.7%	$503K+137.7%	-$1.7M-50.5%
Depreciation & Amortization	$51K-67.1%	$55K-66.8%	$152K-18.1%	$137K-27.1%	$154K-18.4%	$167K-11.4%	$185K-1.1%	$188K-0.1%
Stock-Based Compensation	$163K+123.8%	$116K-61.6%	N/A	N/A	$73K-78.0%	$303K+51.4%	N/A	$320K-62.2%
Capital Expenditures	$8K+20.3%	$6K-76.4%	$20K-14.4%	$10K+173.7%	$7K-72.1%	$26K-44.6%	$23K+65.9%	$4K-67.5%
Free Cash Flow	-$912K+46.0%	-$1000K+35.4%	-$3.8M-887.8%	-$1.2M+31.7%	-$1.7M-88.4%	-$1.5M+4.0%	$480K+135.6%	-$1.8M-49.4%
Investing Cash Flow	$927K+146.0%	$814K-32.4%	$1.4M+218.0%	$864K+0.5%	$377K-65.4%	$1.2M+150.5%	$436K+110.5%	$859K-16.4%
Financing Cash Flow	$0-100.0%	$0	-$100	$500K	$1.5M	$0-100.0%	$0-100.0%	$0-100.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

SCND Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCND quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	25.8%-16.1pp	41.8%-4.1pp	45.9%-4.4pp	50.3%-0.6pp	50.9%+0.3pp	50.6%+7.8pp	42.8%+4.8pp	38.0%+2.7pp	35.3%-5.5pp	40.8%+1.1pp	39.8%+1.3pp	38.5%-3.0pp	41.5%+3.5pp	38.0%-3.0pp	41.0%
Operating Margin	-156.1%	-171.3%	-83.3%	-101.3%	-48.2%-39.6pp	-8.5%-16.1pp	7.6%+7.7pp	-0.1%+1.9pp	-2.0%-4.5pp	2.5%+2.8pp	-0.2%+1.5pp	-1.8%-8.9pp	7.1%+6.5pp	0.6%-4.0pp	4.6%
Net Margin	-24.1%	-134.4%	-81.8%	-119.9%	-37.6%-28.5pp	-9.0%-15.4pp	6.3%+8.2pp	-1.9%-1.0pp	-0.9%-2.6pp	1.7%+1.6pp	0.1%+1.2pp	-1.1%-6.7pp	5.6%+4.5pp	1.1%-2.8pp	3.9%
Return on Equity	-11.5%+59.2pp	-70.7%-5.2pp	-65.4%+12.5pp	-77.9%-63.9pp	-14.0%-8.0pp	-6.0%-16.2pp	10.2%+13.0pp	-2.8%-1.6pp	-1.3%-4.0pp	2.8%+2.6pp	0.1%+1.5pp	-1.3%-8.7pp	7.3%+6.0pp	1.3%-3.6pp	5.0%
Return on Assets	-9.7%+46.1pp	-55.8%-1.4pp	-54.3%+10.7pp	-65.1%-52.4pp	-12.7%-7.9pp	-4.8%-12.6pp	7.8%+10.0pp	-2.2%-1.1pp	-1.1%-3.3pp	2.2%+2.1pp	0.1%+1.2pp	-1.1%-7.5pp	6.4%+5.3pp	1.1%-3.4pp	4.5%
Current Ratio	7.70+3.0x	4.74-2.0x	6.72-0.6x	7.29-0.8x	8.06+2.2x	5.82+1.7x	4.16-0.1x	4.23-1.4x	5.59+1.6x	4.020.0x	4.020.0x	4.02-2.6x	6.64-0.6x	7.26-2.8x	10.03
Debt-to-Equity	0.18-0.1x	0.27+0.1x	0.200.0x	0.20+0.1x	0.11+0.1x	0.00-0.3x	0.31+0.3x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.020.0x	0.00
Asset Turnover	0.400.0x	0.41-0.2x	0.66+0.1x	0.54+0.2x	0.34-0.2x	0.53-0.7x	1.23+0.1x	1.160.0x	1.19-0.1x	1.27+0.2x	1.10+0.1x	0.96-0.2x	1.16+0.1x	1.07-0.1x	1.17
FCF Margin	-162.5%	-78.8%-22.3pp	-56.6%-4.4pp	-52.2%-13.5pp	-38.7%-35.9pp	-2.8%-12.3pp	9.5%+7.2pp	2.3%+1.9pp	0.4%-7.8pp	8.2%+7.2pp	1.0%+1.2pp	-0.2%-7.6pp	7.4%+3.2pp	4.1%-5.9pp	10.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	42.4%+7.5pp	38.3%+1.8pp	-3.5%	45.5%-5.5pp	34.8%-14.0pp	36.5%-5.4pp	N/A	50.9%+5.3pp
Operating Margin	-86.6%	-135.9%	-151.2%	-108.4%	-168.3%	-221.7%	N/A	-117.3%
Net Margin	-83.9%	-129.5%	-117.6%	284.5%	-140.9%	-188.7%	N/A	-88.4%-3.3pp
Return on Equity	-15.3%+4.0pp	-17.4%+5.5pp	-17.9%	32.0%+42.8pp	-19.2%-8.2pp	-22.9%-6.6pp	N/A	-10.8%+11.5pp
Return on Assets	-12.2%+2.7pp	-14.3%+2.5pp	-15.2%	27.4%+36.3pp	-14.9%-5.9pp	-16.8%-3.6pp	N/A	-8.9%+8.0pp
Current Ratio	5.07+0.8x	6.22+2.8x	7.70+3.0x	7.65+1.7x	4.25-1.6x	3.47-2.1x	4.74-2.0x	5.99+2.1x
Debt-to-Equity	0.250.0x	0.22-0.1x	0.18-0.1x	0.170.0x	0.28+0.1x	0.36+0.1x	0.27+0.1x	0.22-0.1x
Asset Turnover	0.150.0x	0.110.0x	0.13	0.100.0x	0.11-0.1x	0.09-0.1x	N/A	0.10-0.1x
FCF Margin	-62.1%	-81.5%	-232.3%	-85.2%	-156.3%	-164.3%	N/A	-131.4%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
SCIENTIFIC INDUSTRIES INC SCND	FY2025	$5.1M	-$1.2M	-24.1%	$8.2M	—
LIFELOC TECHNOLOGIES INC LCTC	FY2025	$9.0M	-$2.5M	-27.4%	$11.0M	—
GLOBAL WARMING SLTNS INC GWSO	FY2023	$0	-$516K	N/A	$1.5M	—
DARKPULSE INC DPLS	FY2025	$308K	-$3.0M	N/A	$906K	—

Where SCIENTIFIC INDUSTRIES INC Ranks

Frequently Asked Questions

What is SCIENTIFIC INDUSTRIES INC's annual revenue?

SCIENTIFIC INDUSTRIES INC (SCND) reported $5.1M in total revenue for fiscal year 2025. This represents a 5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SCIENTIFIC INDUSTRIES INC's revenue growing?

SCIENTIFIC INDUSTRIES INC (SCND) revenue grew by 5.4% year-over-year, from $4.8M to $5.1M in fiscal year 2025.

Is SCIENTIFIC INDUSTRIES INC profitable?

No, SCIENTIFIC INDUSTRIES INC (SCND) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -24.1%.

What is SCIENTIFIC INDUSTRIES INC's EBITDA?

SCIENTIFIC INDUSTRIES INC (SCND) had EBITDA of -$7.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is SCIENTIFIC INDUSTRIES INC's gross margin?

SCIENTIFIC INDUSTRIES INC (SCND) had a gross margin of 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is SCIENTIFIC INDUSTRIES INC's net profit margin?

SCIENTIFIC INDUSTRIES INC (SCND) had a net profit margin of -24.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is SCIENTIFIC INDUSTRIES INC's return on equity (ROE)?

SCIENTIFIC INDUSTRIES INC (SCND) has a return on equity of -11.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is SCIENTIFIC INDUSTRIES INC's free cash flow?

SCIENTIFIC INDUSTRIES INC (SCND) recorded an outflow of $8.2M in free cash flow during fiscal year 2025. This represents a -117.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is SCIENTIFIC INDUSTRIES INC's operating cash flow?

SCIENTIFIC INDUSTRIES INC (SCND) recorded an outflow of $8.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are SCIENTIFIC INDUSTRIES INC's total assets?

SCIENTIFIC INDUSTRIES INC (SCND) had $12.6M in total assets as of fiscal year 2025, including both current and long-term assets.

What are SCIENTIFIC INDUSTRIES INC's capital expenditures?

SCIENTIFIC INDUSTRIES INC (SCND) invested $63K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does SCIENTIFIC INDUSTRIES INC spend on research and development?

SCIENTIFIC INDUSTRIES INC (SCND) invested $2.5M in research and development during fiscal year 2025.

How many shares does SCIENTIFIC INDUSTRIES INC have outstanding?

SCIENTIFIC INDUSTRIES INC (SCND) had 12M shares outstanding as of fiscal year 2025.

What is SCIENTIFIC INDUSTRIES INC's current ratio?

SCIENTIFIC INDUSTRIES INC (SCND) had a current ratio of 7.70 as of fiscal year 2025, which is generally considered healthy.

What is SCIENTIFIC INDUSTRIES INC's debt-to-equity ratio?

SCIENTIFIC INDUSTRIES INC (SCND) had a debt-to-equity ratio of 0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is SCIENTIFIC INDUSTRIES INC's return on assets (ROA)?

SCIENTIFIC INDUSTRIES INC (SCND) had a return on assets of -9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is SCIENTIFIC INDUSTRIES INC's P/E ratio?

SCIENTIFIC INDUSTRIES INC (SCND) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $8.2M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SCIENTIFIC INDUSTRIES INC's price-to-sales ratio?

SCIENTIFIC INDUSTRIES INC (SCND) trades at 1.4x sales, its market capitalization divided by revenue of $5.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $8.2M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does SCIENTIFIC INDUSTRIES INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, SCIENTIFIC INDUSTRIES INC (SCND) held $6.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.1M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is SCIENTIFIC INDUSTRIES INC's Altman Z-Score?

SCIENTIFIC INDUSTRIES INC (SCND) has an Altman Z-Score of -2.19, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is SCIENTIFIC INDUSTRIES INC's Piotroski F-Score?

SCIENTIFIC INDUSTRIES INC (SCND) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SCIENTIFIC INDUSTRIES INC's earnings high quality?

SCIENTIFIC INDUSTRIES INC (SCND) reported a net loss of $1.2M while operations used $8.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.